Organon (NYSE: OGN) revenue
Organon reported revenue of $6,216m for fiscal 2025, 2.9% less than in fiscal 2024 ($6,403m). Since fiscal 2020 its revenue has fallen by 4.8%, an average decline of 1.0% a year.
Organon's best year of the last 6 was fiscal 2020. The biggest drop was in fiscal 2021, −3.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $6,216m | −2.9% | $929.0m | 14.9% |
| 2024 | $6,403m | +2.2% | $1,327m | 20.7% |
| 2023 | $6,263m | +1.4% | $1,200m | 19.2% |
| 2022 | $6,174m | −2.1% | $1,544m | 25.0% |
| 2021 | $6,304m | −3.5% | $1,787m | 28.3% |
| 2020 | $6,532m | — | $2,752m | 42.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Organon revenue compared with its sector
By revenue for its latest fiscal year, Organon ranks 52nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Organon, −2.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 50th | Avantor | $6,552m | −3.4% |
| 51st | Ardent Health | $6,324m | 6.0% |
| 52nd | Organon | $6,216m | −2.9% |
| 53rd | Edwards Lifesciences | $6,068m | 11.5% |
| 54th | Steris | $5,936m | 8.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Organon
- How much revenue did Organon make in fiscal 2025?
- Organon reported revenue of $6,216m for fiscal 2025, compared with $6,403m in fiscal 2024.
- How much has the revenue of Organon fallen?
- Between fiscal 2020 and fiscal 2025 it went from $6,532m to $6,216m: 4.8% less, an average decline of 1.0% a year.
- What was the best year for revenue at Organon?
- Of its last 6 fiscal years, fiscal 2020, with $6,532m.
- Where does Organon rank in its sector by revenue?
- It ranks 52nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Organon come from?
- From the annual report (Form 10-K) that Organon files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Organon files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Organon: the Organon page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Organon by fiscal year, with the filing behind every figure: Organon dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.